The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 08, 2023
Filed:
Jul. 29, 2021
Applicant:
Hadasit Medical Research Services and Development Ltd., Jerusalem, IL;
Inventor:
Rifaat Safadi, Nazareth Elit, IL;
Assignee:
HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD., Jerusalem, IL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 38/16 (2006.01); A61K 38/17 (2006.01); A61P 1/16 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); A61K 38/16 (2013.01); A61K 38/177 (2013.01); A61K 38/1709 (2013.01); A61P 1/16 (2018.01); A61K 2039/505 (2013.01); C07K 2317/34 (2013.01); C07K 2317/52 (2013.01); C07K 2317/76 (2013.01); C07K 2319/30 (2013.01);
Abstract
Method for treating, attenuating and/or preventing progression of a liver disorder in a subject, the method including administering a therapeutically effective amount of an agent capable of interfering with, inhibiting and/or preventing neuroligin 4 (NLGn4)-Neurexin 1-beta (Nrx1b) protein-protein interaction; and compositions including the agent.
Quick Actions:
Safadi, Rifaat. (2023). Inhibitors of neuroligin 4-neurexin 1-beta protein-protein interaction for treatment of liver disorders (U.S. Patent No. 11718666). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11718666
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile